Mount Sinai Hospital in Long Island City, NY, can earn VBP incentives by reducing MSPB costs by 1.4%

In Mount Sinai Hospital

No Image

By: Sharath Joji  Jun. 24, 2021

Mount Sinai Hospital in Long Island City, NY, reported a CMS Value Based Purchasing (VBP) Adjustment Factor of 0.9991 in the year 2021, which could result in an estimated penalty of $199,841. Medicare Spending Per Beneficiary (MSPB) accounts for 25% of overall VBP score and is a significant factor in driving VBP payments. MSPB costs include the costs from 3 days before hospitalization, index hospital stays, and 30 days post-discharge. The measure score of the Efficiency & Cost Reduction domain for Mount Sinai Hospital during the period was 1/10. Dexur is an approved purchaser of CMS Medicare claims data and based on our simulator, we estimate that Mount Sinai Hospital can avoid VBP penalties by reducing MSPB Costs by 1.4%.

Read more

Mount Sinai Hospital’s Percutaneous Intracardiac Procedures’ MSPB average increased by 13%

In Mount Sinai Hospital

No Image

By: Parvathy Rajagopal  Oct. 16, 2020

Dexur analyzed Medicare Claims data and replicated CMS algorithms to calculate Medicare Spending per Beneficiary (MSPB) cost per episode of Vanderbilt University Medical Center and found that the cost per episode was $62,525 for Percutaneous Intracardiac Procedures from Jan-Dec 2019. The cost increased by 12.7% in 2019 to reach $62,525 compared to $55,483 in 2018. MSPB is the only measure under the Efficiency and Cost Reduction domain under the Value-Based Purchasing (VBP) Program and accounts for 25% of VBP adjustments.

Read more

Dr. Sharma and Dr. Kini of The Mount Sinai Hospital are 2 of the Top 3 Highest Volume Cardiovascular Physicians in the U.S.

In The Mount Sinai Hospital

By: Jeffrey Maser  Dec. 04, 2017

Recent Dexur research on Medicare inpatient cardiovascular discharges between October 2015 - September 2016 showed that Dr. Samin Sharma, of The Mount Sinai Hospital in New York, New York, was the highest volume cardiovascular physician in the U.S. During the time period, Dr. Sharma accounted for 641 out of the 1,972,008 toal cardiovascular discharges from U.S. Medicare enrollees to make up 0.03% of the national market share.

Read more